Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle  
10/29/13Vitae Pharmaceuticals named one of the Best Places to Work in PA 2013
Announcement marks fourth consecutive year Vitae has made the list FORT WASHINGTON, PA – October 29, 2013 – Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing novel, small molecule, best-in-class compounds, today announced it was named one of Central Penn Business Journal’s 100 Best Places to Work in PA for 2013. The company will be honored at a reception on Thursday, Dec. 5, at the Lancaster County Convention ... 
Download PDFPrinter Friendly Version
10/21/13Vitae Pharmaceuticals, Dow Corning, And Johnson & Johnson Share Their Policies For Attracting And Retaining The Best Employees.
... 
Printer Friendly Version
08/01/13Vitae’s executive team talks about innovation in drug discovery on The In Vivo Blog
One of the best things about having time to sit down with a company's executive team and discuss matters such as pipeline and business strategy at leisure is the chance to intersperse more philosophical questions that address how a company views itself and the work environment it tries to provide. In meeting a few weeks ago with the executive team at Vitae Pharmaceuticals near Philadelphia for a profile in "The Pink Sheet," I got more information than I could process on the firm... 
Download PDFPrinter Friendly Version
07/29/13Read The Pink Sheet’s profile of Vitae Pharmaceuticals
... 
Printer Friendly Version
06/12/13Vitae Pharmaceuticals is ranked #2 in The Scientist magazine’s annual “Best Places to Work” survey
Vitae ranked second overall in life sciences industry; highest-ranked U.S. company Survey measured responses of more than 200 companies worldwide Fort Washington, PA, June 12, 2013 – Vitae Pharmaceuticals, Inc., a clinical‐stage biopharmaceutical company discovering and developing novel, small molecule, best‐in‐class compounds, today announced that the company ranked second among life sciences companies in the 11th annual Best Places to Work in Industry survey conducted by The Scient... 
Download PDFPrinter Friendly Version
06/04/13Progress update of Vitae’s RORγt inhibitor program
Robust efficacy results achieved in multiple sclerosis mouse model with record-breaking speed Vitae’s time from initiation of program to animal proof-of-principle with qualified lead has consistently been less than 18 months FORT WASHINGTON, PA – June 4, 2013 – Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing novel, small molecule, first- and bestin-class compounds, today announced that it has achieved animal proof-of-principle of ... 
Download PDFPrinter Friendly Version
02/20/13Read Vitae CEO Jeff Hatfield’s views on the Life Sciences market in the Grant Thornton Life Sciences spotlight
... 
Printer Friendly Version